CXT
Crane NXT, Co.
CXT trails on the overall score without a compensating advantage in the available component scores.
VRT
Vertiv Holdings Co
VRT has the edge over CXT overall, supported by stronger valuation and stronger modeled upside.
CXT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Under pressure |
CXT's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is under pressure.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
CXT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $56.99 | — |
| Cheap | 15x | $32.96 | -42% |
| Fair | 19x | $41.21 | -28% |
| Current | 26x | $56.99 | — |
| Expensive | 27x | $60.07 | +5.4% |
Historical ranges are pointers, not guarantees.
CXT's PE is in its expensive range at 26x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its cheap range.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over CXT in the historical PE scenario, which offers more potential upside but is not a forecast.
CXT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CXT, but weaker profitability.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
VRT has the edge over CXT on the outlook, with more favorable profitability expectations.
CXT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.58 | +108% |
| Q3 2026 | $2.20 | -18% |
| Q2 2026 | $2.41 | -8% |
| Q1 2026 | $2.23 | -23% |
| Q4 2025 | $2.50 | -22% |
| Q3 2025 | $2.68 | -12% |
| Q2 2025 | $2.62 | -17% |
| Q1 2025 | $2.91 | -8.2% |
| Q4 2022 | $2.43 | -4.7% |
CXT's earnings per share have fallen from their peak: $2.20 over the past year, against $3.31 in mid-2022.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over CXT on earnings, with more consistent year-over-year improvement.
CXT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $497.1M | +12% |
| Q2 2026 | $493.2M | +22% |
| Q1 2026 | $387.7M | +17% |
| Q4 2025 | $476.9M | +19% |
| Q3 2025 | $445.1M | +10% |
| Q2 2025 | $404.4M | +9.1% |
| Q1 2025 | $330.3M | +5.3% |
| Q4 2024 | $399.1M | +12% |
CXT's revenue has grown year over year for 10 quarters in a row: $497M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | -5.2 points |
| Q2 2026 | 14% | +2.1 points |
| Q1 2026 | 5.7% | -5.6 points |
| Q4 2025 | 17% | -1 points |
| Q3 2025 | 18% | -0.2 points |
| Q2 2025 | 12% | -6.4 points |
| Q1 2025 | 11% | -6.4 points |
| Q4 2024 | 18% | -2.6 points |
CXT's operating margin was 13% last quarter, down 5.2 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over CXT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over CXT on profitability, with a higher operating margin.
CXT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $90.2M | +15% |
| Q2 2026 | $73.4M | +32% |
| Q1 2026 | -$24.1M | +$8.1M |
| Q4 2025 | $96M | +37% |
| Q3 2025 | $78.7M | +47% |
| Q2 2025 | $55.8M | +16% |
| Q1 2025 | -$32.2M | -$29.2M |
| Q4 2024 | $70.3M | +11% |
CXT still generates free cash flow, though less than at its 2019 peak: $236M over the past year.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT generated $3.1B in free cash flow over the past year, up 127% from the year before.
CXT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +100K shares |
| 1 year | +0.2% | +100K shares |
| 3 years | +1% | +600K shares |
| 5 years | -66% | -113M shares |
| Available history | -67% | -116M shares |
CXT has the edge over VRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $27.9M |
| Q1 2022 | $175.8M |
| Q4 2021 | $96.3M |
| Q3 2021 | — |
| Q2 2021 | — |
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has 393M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
CXT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.7x | Elevated |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 3.0x | Moderate |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.6x | Healthy |
CXT's net debt is about 3.0 years of its operating earnings (EBITDA), up from 2.6 years a year ago.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over CXT on leverage, with a lower net debt burden relative to earnings.
CXT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.5 | Neutral |
| Stochastic | 73.0 | Neutral |
CXT's weekly RSI is 61 (neutral) and its Stochastic is 73 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
CXT PE vs Industrials Sector
| Metric | CXT | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 24x | 7.8% above |
| PE % | 82 | 58 | 24 pts above |
CXT has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
CXT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $54.0 | 5.6% above |
| 20 week MA | $52.2 | 9.2% above |
| 50 week MA | $48.8 | 17% above |
| 100 week MA | $53.1 | 7.3% above |
| 200 week MA | $54.1 | 5.4% above |
CXT has the edge over VRT on trend strength, trading above more of its moving averages.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
CXT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.0 | $26.7 | -11% |
| 2021 | $26.7 | $34.6 | +30% |
| 2022 | $34.6 | $34.6 | -0.2% |
| 2023 | $34.6 | $56.9 | +65% |
| 2024 | $56.9 | $58.0 | +2% |
| 2025 | $58.0 | $48.4 | -17% |
| 2026 YTD | $48.4 | $57.0 | +18% |
CXT has finished lower in three of the last six years. It's up 18% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over CXT on returns for 2026, with the stronger performance.